HEADER CHAPERONE/CHAPERONE INHIBITOR 22-FEB-11 3QTF TITLE DESIGN AND SAR OF MACROCYCLIC HSP90 INHIBITORS WITH INCREASED TITLE 2 METABOLIC STABILITY AND POTENT CELL-PROLIFERATION ACTIVITY COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEAT SHOCK PROTEIN HSP 90-ALPHA; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: N-TERMINAL DOMAIN (UNP RESIDUES 10-236); COMPND 5 SYNONYM: HEAT SHOCK 86 KDA, HSP 86, HSP86, RENAL CARCINOMA ANTIGEN COMPND 6 NY-REN-38; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HSP90A, HSP90AA1, HSPC1, HSPCA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS CHAPERONE, ATP BINDING DOMAIN, ATP-BINDING, NUCLEOTIDE-BINDING, KEYWDS 2 PHOSPHOPROTEIN, STRESS RESPONSE, CHAPERONE-CHAPERONE INHIBITOR KEYWDS 3 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.W.ZAPF,J.D.BLOOM,J.L.MCBEAN,R.G.DUSHIN,T.NITTOLI,C.INGALLS, AUTHOR 2 A.G.SUTHERLAND,J.P.SONYE,C.N.EID,J.GOLAS,H.LIU,F.BOSCHELLI,Y.HU, AUTHOR 3 E.M.VOGAN,J.I.LEVIN REVDAT 3 21-FEB-24 3QTF 1 REMARK SEQADV REVDAT 2 20-APR-11 3QTF 1 JRNL REVDAT 1 06-APR-11 3QTF 0 JRNL AUTH C.W.ZAPF,J.D.BLOOM,J.L.MCBEAN,R.G.DUSHIN,T.NITTOLI, JRNL AUTH 2 C.INGALLS,A.G.SUTHERLAND,J.P.SONYE,C.N.EID,J.GOLAS,H.LIU, JRNL AUTH 3 F.BOSCHELLI,Y.HU,E.VOGAN,J.I.LEVIN JRNL TITL DESIGN AND SAR OF MACROCYCLIC HSP90 INHIBITORS WITH JRNL TITL 2 INCREASED METABOLIC STABILITY AND POTENT CELL-PROLIFERATION JRNL TITL 3 ACTIVITY. JRNL REF BIOORG.MED.CHEM.LETT. V. 21 2278 2011 JRNL REFN ISSN 0960-894X JRNL PMID 21420297 JRNL DOI 10.1016/J.BMCL.2011.02.101 REMARK 2 REMARK 2 RESOLUTION. 1.57 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.57 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 22.68 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 77.5 REMARK 3 NUMBER OF REFLECTIONS : 32785 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.188 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.204 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.070 REMARK 3 FREE R VALUE TEST SET COUNT : 1663 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 22.6819 - 3.5908 0.86 3031 145 0.1589 0.1741 REMARK 3 2 3.5908 - 2.8519 0.97 3327 167 0.1722 0.1648 REMARK 3 3 2.8519 - 2.4919 0.95 3149 181 0.1869 0.2140 REMARK 3 4 2.4919 - 2.2643 0.92 3079 171 0.1908 0.2120 REMARK 3 5 2.2643 - 2.1021 0.94 3147 174 0.1851 0.2182 REMARK 3 6 2.1021 - 1.9783 0.93 3090 156 0.1937 0.1951 REMARK 3 7 1.9783 - 1.8792 0.89 2948 170 0.2051 0.2422 REMARK 3 8 1.8792 - 1.7975 0.61 2033 100 0.2340 0.2862 REMARK 3 9 1.7975 - 1.7283 0.68 2226 128 0.2335 0.2180 REMARK 3 10 1.7283 - 1.6687 0.67 2229 114 0.2395 0.2493 REMARK 3 11 1.6687 - 1.6165 0.52 1714 105 0.2576 0.2769 REMARK 3 12 1.6165 - 1.5703 0.34 1149 52 0.2949 0.3449 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.37 REMARK 3 B_SOL : 52.32 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.160 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.990 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.44 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.47120 REMARK 3 B22 (A**2) : 0.93180 REMARK 3 B33 (A**2) : -4.76870 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 1705 REMARK 3 ANGLE : 0.823 2306 REMARK 3 CHIRALITY : 0.060 261 REMARK 3 PLANARITY : 0.003 293 REMARK 3 DIHEDRAL : 13.404 629 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3QTF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-FEB-11. REMARK 100 THE DEPOSITION ID IS D_1000064080. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-JUN-08 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E+ SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : OSMIC MIRRORS REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 92 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32785 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.570 REMARK 200 RESOLUTION RANGE LOW (A) : 22.700 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 77.5 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.34 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.95 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 18.4% PEG3350, 0.2M MAGNESIUM NITRATE, REMARK 280 PROTEIN @ 13.5 MG/ML, TEMPERATURE 277K; FROZEN BY 1-STEP REMARK 280 TRANSFER TO 25% GLYCEROL, 14% PEG3350, 0.15M MAGNESIUM NITRATE, REMARK 280 PH 7.5, VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 33.63200 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 45.35900 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 49.18950 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 33.63200 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 45.35900 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 49.18950 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 33.63200 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 45.35900 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 49.18950 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 33.63200 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 45.35900 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 49.18950 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 11 REMARK 465 PRO A 12 REMARK 465 MET A 13 REMARK 465 GLU A 14 REMARK 465 GLU A 15 REMARK 465 GLU A 16 REMARK 465 LYS A 224 REMARK 465 GLU A 225 REMARK 465 ARG A 226 REMARK 465 ASP A 227 REMARK 465 LYS A 228 REMARK 465 GLU A 229 REMARK 465 VAL A 230 REMARK 465 SER A 231 REMARK 465 ASP A 232 REMARK 465 ASP A 233 REMARK 465 GLU A 234 REMARK 465 ALA A 235 REMARK 465 GLU A 236 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 38 108.14 -161.58 REMARK 500 ALA A 166 -146.45 66.15 REMARK 500 ARG A 182 138.84 -171.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 05S A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMS A 237 DBREF 3QTF A 11 236 UNP P07900 HS90A_HUMAN 10 236 SEQADV 3QTF A UNP P07900 GLU 16 DELETION SEQRES 1 A 226 GLN PRO MET GLU GLU GLU VAL GLU THR PHE ALA PHE GLN SEQRES 2 A 226 ALA GLU ILE ALA GLN LEU MET SER LEU ILE ILE ASN THR SEQRES 3 A 226 PHE TYR SER ASN LYS GLU ILE PHE LEU ARG GLU LEU ILE SEQRES 4 A 226 SER ASN SER SER ASP ALA LEU ASP LYS ILE ARG TYR GLU SEQRES 5 A 226 SER LEU THR ASP PRO SER LYS LEU ASP SER GLY LYS GLU SEQRES 6 A 226 LEU HIS ILE ASN LEU ILE PRO ASN LYS GLN ASP ARG THR SEQRES 7 A 226 LEU THR ILE VAL ASP THR GLY ILE GLY MET THR LYS ALA SEQRES 8 A 226 ASP LEU ILE ASN ASN LEU GLY THR ILE ALA LYS SER GLY SEQRES 9 A 226 THR LYS ALA PHE MET GLU ALA LEU GLN ALA GLY ALA ASP SEQRES 10 A 226 ILE SER MET ILE GLY GLN PHE GLY VAL GLY PHE TYR SER SEQRES 11 A 226 ALA TYR LEU VAL ALA GLU LYS VAL THR VAL ILE THR LYS SEQRES 12 A 226 HIS ASN ASP ASP GLU GLN TYR ALA TRP GLU SER SER ALA SEQRES 13 A 226 GLY GLY SER PHE THR VAL ARG THR ASP THR GLY GLU PRO SEQRES 14 A 226 MET GLY ARG GLY THR LYS VAL ILE LEU HIS LEU LYS GLU SEQRES 15 A 226 ASP GLN THR GLU TYR LEU GLU GLU ARG ARG ILE LYS GLU SEQRES 16 A 226 ILE VAL LYS LYS HIS SER GLN PHE ILE GLY TYR PRO ILE SEQRES 17 A 226 THR LEU PHE VAL GLU LYS GLU ARG ASP LYS GLU VAL SER SEQRES 18 A 226 ASP ASP GLU ALA GLU HET 05S A 1 30 HET DMS A 237 4 HETNAM 05S (6S)-6,15,15,18-TETRAMETHYL-17-OXO-2,3,4,5,6,7,14,15, HETNAM 2 05S 16,17-DECAHYDRO-1H-8,12-(METHENO)[1,4, HETNAM 3 05S 9]TRIAZACYCLOTETRADECINO[9,8-A]INDOLE-9-CARBOXAMIDE HETNAM DMS DIMETHYL SULFOXIDE FORMUL 2 05S C24 H32 N4 O2 FORMUL 3 DMS C2 H6 O S FORMUL 4 HOH *311(H2 O) HELIX 1 1 GLN A 23 THR A 36 1 14 HELIX 2 2 GLU A 42 ASP A 66 1 25 HELIX 3 3 PRO A 67 ASP A 71 5 5 HELIX 4 4 THR A 99 ASN A 105 1 7 HELIX 5 5 ASN A 105 ALA A 124 1 20 HELIX 6 6 ASP A 127 GLY A 135 5 9 HELIX 7 7 VAL A 136 LEU A 143 5 8 HELIX 8 8 GLU A 192 LEU A 198 5 7 HELIX 9 9 GLU A 199 SER A 211 1 13 SHEET 1 A 8 GLU A 18 ALA A 21 0 SHEET 2 A 8 SER A 169 THR A 174 -1 O PHE A 170 N PHE A 20 SHEET 3 A 8 GLN A 159 SER A 164 -1 N ALA A 161 O ARG A 173 SHEET 4 A 8 ALA A 145 LYS A 153 -1 N VAL A 150 O TRP A 162 SHEET 5 A 8 GLY A 183 LEU A 190 -1 O ILE A 187 N THR A 149 SHEET 6 A 8 THR A 88 ASP A 93 -1 N LEU A 89 O LEU A 188 SHEET 7 A 8 ILE A 78 ASN A 83 -1 N ILE A 81 O THR A 90 SHEET 8 A 8 ILE A 218 LEU A 220 1 O THR A 219 N LEU A 80 SITE 1 AC1 13 HOH A 2 HOH A 4 ALA A 55 ASP A 93 SITE 2 AC1 13 ILE A 96 MET A 98 LEU A 107 TYR A 139 SITE 3 AC1 13 TRP A 162 THR A 184 HOH A 282 HOH A 313 SITE 4 AC1 13 HOH A 414 SITE 1 AC2 6 HIS A 77 ASN A 79 PHE A 221 HOH A 261 SITE 2 AC2 6 HOH A 367 HOH A 455 CRYST1 67.264 90.718 98.379 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014867 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011023 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010165 0.00000